Selectra Biosciences

Selecta's rapamycin nanoparticles could enable re-dosing of gene therapies
BioCentury
Fri, 10/5/18 - 09:15 pm
Selectra Biosciences
SVP-Rapamycin
nanoparticles
gene therapy